BIOA vs GILD · rev $9.0M vs P/E 18, rev $7.80B
BioAge Labs, Inc (BIOA) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
BioAge Labs, Inc (BIOA) is a drug manufacturers - specialty & generic company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported BIOA revenue for 2025-12-31 was $9.0M. Net income was -$80.6M. BIOA currently screens at market cap $697.9M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BIOA currently screens at market cap $697.9M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BIOA and GILD stock pages for the full models.
Not investment advice.